90930-90-8Relevant articles and documents
SPIROCYCLIC TETRAHYDROQUINAZOLINES
-
, (2021/07/17)
Provided are compounds represented by Formula I, wherein R3, A, A1, A2, A3, E, E1, E2, L, Q, Z, and (aa) are as defined in the specification, and the pharmaceutically acceptable salts and solvates thereof. Compounds of Formula (I) are KRAS inhibitors and are thus useful to treat cancer and other diseases.
A new synthesis of morphine-based analgesics
Chandler,Parsons
, p. 322 - 323 (2007/10/02)
-